Aviptadil acetate is a synthetic peptide derived from vasoactive intestinal peptide (VIP), which is known for its neuroprotective and anti-inflammatory properties. It is primarily recognized for its potential therapeutic applications in treating respiratory conditions, particularly acute respiratory distress syndrome (ARDS) and other lung-related diseases. The substance acts by promoting vasodilation, enhancing mucosal blood flow, and exhibiting anti-inflammatory effects, which can be beneficial in mitigating lung injury. Aviptadil acetate is administered via inhalation or injection, allowing for targeted delivery to the respiratory system. Its mechanism of action involves binding to specific VIP receptors, leading to various cellular responses that support lung function and repair. The compound has garnered attention in clinical research, especially during the COVID-19 pandemic, for its potential to alleviate severe respiratory symptoms. As with any therapeutic agent, the safety and efficacy of Aviptadil acetate are subject to ongoing investigation, and it is essential to consider potential side effects and contraindications in clinical use.

Aviptadil acetate

1444827-29-5: Aviptadil acetate is a synthetic peptide derived from vasoactive intestinal peptide (VIP), which is known for its neuroprotective and anti-inflammatory properties. It is primarily recognized for its potential therapeutic applications in treating respiratory conditions, particularly acute respiratory distress syndrome (ARDS) and other lung-related diseases. The substance acts by promoting vasodilation, enhancing mucosal blood flow, and exhibiting anti-inflammatory effects, which can be beneficial in mitigating lung injury. Aviptadil acetate is administered via inhalation or injection, allowing for targeted delivery to the respiratory system. Its mechanism of action involves binding to specific VIP receptors, leading to various cellular responses that support lung function and repair. The compound has garnered attention in clinical research, especially during the COVID-19 pandemic, for its potential to alleviate severe respiratory symptoms. As with any therapeutic agent, the safety and efficacy of Aviptadil acetate are subject to ongoing investigation, and it is essential to consider potential side effects and contraindications in clinical use.

Aviptadil Acetate

Aviptadil Acetate (Vasoactive Intestinal Peptide acetate salt) induces pulmonary vasodilation and inhibits the proliferation of vascular SMCs.

CAS 1444827-29-5

Aviptadil acetate

Aviptadil Acetate

Ref: 54-BUP20089

Aviptadil Acetate

Ref: TM-TP1016L